Total Payments
$2,366
2022 Payments
$515.28
Companies
5
Transactions
15
Medicare Patients
1,297
Medicare Billing
$252,441
Payment Breakdown by Category
Travel$1,579 (66.8%)
Food & Beverage$786.15 (33.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,579 | 3 | 66.8% |
| Food and Beverage | $786.15 | 12 | 33.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,472 | 7 | $0 (2019) |
| Intuitive Surgical, Inc. | $515.28 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $244.63 | 3 | $0 (2019) |
| TESARO, Inc. | $120.23 | 1 | $0 (2019) |
| Stryker Corporation | $13.18 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $515.28 | 3 | Intuitive Surgical, Inc. ($515.28) |
| 2021 | $13.18 | 1 | Stryker Corporation ($13.18) |
| 2019 | $1,793 | 10 | Merck Sharp & Dohme Corporation ($1,472) |
| 2018 | $44.08 | 1 | AstraZeneca Pharmaceuticals LP ($44.08) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: SURGERY | ||||||
| 07/05/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $455.62 | General |
| Category: SURGERY | ||||||
| 07/05/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: SURGERY | ||||||
| 07/27/2021 | Stryker Corporation | SPY-PHI SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: ENDOSCOPY | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $49.53 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $44.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $929.45 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $194.35 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $115.25 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $104.68 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $83.07 | General |
| 09/12/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $120.23 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $117.48 | General |
| Category: Oncology | ||||||
| 10/16/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 513 | 641 | $379,657 | $93,595 |
| 2022 | 13 | 473 | 562 | $449,666 | $97,772 |
| 2021 | 9 | 239 | 263 | $214,576 | $50,251 |
| 2020 | 4 | 72 | 108 | $29,825 | $10,823 |
Total Patients
1,297
Total Services
1,574
Medicare Billing
$252,441
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 33 | 33 | $129,954 | $24,017 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 205 | $30,955 | $13,132 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 120 | $26,280 | $10,918 | 41.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $26,102 | $10,176 | 39.0% |
| 58661 | Removal of ovaries and/or tubes using an endoscope | Facility | 2023 | 13 | 13 | $17,836 | $9,316 | 52.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $18,315 | $7,185 | 39.2% |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | Facility | 2023 | 22 | 22 | $93,786 | $4,386 | 4.7% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 24 | 24 | $7,608 | $4,020 | 52.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 23 | $6,762 | $2,909 | 43.0% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2023 | 15 | 15 | $7,930 | $2,362 | 29.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $6,225 | $2,018 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 23 | $3,404 | $1,377 | 40.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,038 | $1,144 | 37.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 17 | $1,462 | $634.56 | 43.4% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 42 | 42 | $165,396 | $31,216 | 18.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 64 | 64 | $26,944 | $10,878 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 99 | $21,681 | $9,189 | 42.4% |
| 58661 | Removal of ovaries and/or tubes using an endoscope | Facility | 2022 | 14 | 14 | $27,988 | $8,420 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 126 | $19,026 | $8,351 | 43.9% |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | Facility | 2022 | 31 | 31 | $132,153 | $6,540 | 4.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $16,317 | $5,804 | 35.6% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 32 | 32 | $9,928 | $5,160 | 52.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 30 | $8,820 | $4,314 | 48.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $7,055 | $2,681 | 38.0% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2022 | 12 | 12 | $6,230 | $2,293 | 36.8% |
About Dr. Beverly Long, M.D
Dr. Beverly Long, M.D is a Gynecologic Oncology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1932497245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beverly Long, M.D has received a total of $2,366 in payments from pharmaceutical and medical device companies, with $515.28 received in 2022. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($1,579).
As a Medicare-enrolled provider, Long has provided services to 1,297 Medicare beneficiaries, totaling 1,574 services with total Medicare billing of $252,441. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Sarasota, FL
- Active Since 07/20/2011
- Last Updated 10/16/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1932497245
Products in Payments
- MK-7339 (Drug) $1,368
- Da Vinci Surgical System (Device) $515.28
- ZEJULA (Drug) $120.23
- LYNPARZA (Drug) $117.48
- KEYTRUDA (Biological) $104.68
- SPY-PHI SYSTEM (Device) $13.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.